The article discusses state of the direct-to-consumer (DTC) genetic testing industry. It discusses launch of the Impact of Personal Genomics (PGen) Study to provide the before and after survey of DTC genetic testing customers. It mentions blocking over-the-counter sales of DTC genetic tests from Pathway Genomics firm by Food and Drug Administration (FDA).